IN THEM OLD OXYCONTIN FIELDS

BACK HOME
https://www.youtube.com/watch?v=C4zPEmRufMU

When Rudy got really rotten

He started distributing OxyContin
In them old Oxycontin Fields back home
It was with Purdue Pharma
He developed really bad Karma
In them old Oxycontin Fields back home
When Rudy was a little bitty baby
Father Alan Placa would rob the cradel
In them old Oxycontin Fields back home
1
 In 2002 Rudy Giuliani got his OxyContin-pickin’ hands
on some serious drug money after he hooked up with
Purdue Pharma, a lab that produced the most widely used
opiate turned into powered form there is little difference
between it and heroin or morphine. Purdue Pharma is a
wholly owned subsidiary of Purdue Frederick
Pharmaceuticals, a privately owned corporation controlled
by the Sackler family.

America saved these Jews from the Holocaust and how

did they repay her? By poisoning its inhabitants!

In 1949 Mortimer D. Sackler, Raymond R. Sackler

and their brother Arthur M. Sackler were three
psychiatrists who experimented on what The New York
Times termed “mental cases” at Creedmoor State
Hospital. The Sackler Brothers claimed that injections of
histamine along with electro-convulsive shock treatment
2
could mitigate mental illness.1 By 1950 they were giving
mentally ill people, depending on their sex, massive doses
of testosterone or estradiol, male and female sex
hormones.2 In 1951 the Brothers developed a sonic blood
test that they claimed could distinguish the sane from the
insane.3 Other scientists later discredited all this research
however it was one of the first attempts to combat and
identify mental illness via chemotherapy and biochemistry
respectively. In 1952 the brothers bought a small New
York Drug Company called Purdue Frederick, which had
been founded as early as 1892 by Dr. John Purdue Gray
and George Frederick Bingham.

THE SACKLER’S WERE RED DIAPER BABIES

3
 Ilene Sackler Lefcourt is the director of the Sackler
Lefcourt Center for Child Development in New York, which
she established in 1982 for violent autistic kids. She is a
lecturer in psychiatry at the parent-infant program of the
Columbia University Center for Psychoanalytic Training
and Research. Gerald B. Lefcourt leads a New York law
firm bearing his name, which has defended the Black
Panthers, Abbie Hoffman and every Leftist you can
imagine. Although Gerry kept his distance from Islamist
mass murderers his associate, Josh Dratel did not. I
worked with Abbie and Lefcourt in the Law Commune, on
Broadway and Bleecker Street in Manhattan. Lefcourt and
Marty Stoller represented me. Ilene’s father, Dr. Mortimer
D. Sackler of London, endowed the Mortimer D. Sackler
and Theresa Sackler Gallery at the Metropolitan Museum
of Art and the Sackler Center for Arts Education at the
Guggenheim Museum when he wasn't busy getting
Americans addicted to tranquillizers and heroin analogues.

In May 1953 Raymond and Mortimer Sackler were

dropped from the staff of Creedmoor State Hospital for
refusal to sign an Army loyalty oath. The doctors were
inducted into the service as privates. Arthur Sackler was a
consultant at Creedmoor but not a member of the regular
staff and was not involved in the loyalty oath issue.
According to The New York Times, “The three brothers
4
have been working at the mental hospitals Institute of
Psychobiologic Studies on a research project for the
Atomic Energy Commission on skin reaction to burns.”4
These nice Jewish boys were keeping a puritan traditional
going – burning crazy people - although not at the stake.
In 1954 Arthur Sackler became president of Douglas
McAdams Inc an agency specializing in medical and
pharmaceutical advertising.5 The Sackler family also
owned the Medical Tribune Group, a collection of medical
publications.

In January 1962 Senator Estes Kefauver questioned

Arthur Sackler about the drug MER-29. The producer of
the drug had admitted that it caused serious side effects
5
such as liver disorders, irreversible cataracts, loss of hair
etc. in 3,000 of the 300,000 patients who had taken it.
Senator Kefauver asked Sackler why his agency had
placed an ad in a medical journal that said, “We know that
after use in 300,000 patients few toxic or serious side
effects have been established.”6 According to Merck Index
the compound was withdrawn from the market in 1962.
“CASE4. A 23-year-old male medical student had
participated in a clinical investigation of the drug at
another institution. He was healthy and was taking the
drug as a normal control. He took 1000 mg. of triparanol
daily from February 12 to April 4, 1961 (8 weeks) and
1500 mg. daily from April 5 to May 17, 1961 (6 weeks).
The drug was discontinued on May 17, 1961. Dryness of
the skin and loss of color of the hair had occurred in April
1961. Appearance of 23-year-old medical student who
was a normal control in a clinical investigation of
triparanol. Left, note loss of color of hair and eyebrows.
Right, shows return of normal color of hair 8 months after
drug was stopped and 2 months before cataracts
developed. In the middle of May 1961 his eyes and eyelids
became irritated; there was conjunctivitis followed by iritis
of each eye. The eyes healed, with topical treatment, by
July 1961. His visual acuity was normal and follow-up slit-
lamp examinations revealed no activity of the iritis and no
cataract change until April 1962. On April 4, 1962, nearly

6
one year after administration of the drug was stopped,
posterior subcapsular cataracts were found in each eye.7

In the 1960’s and 1970’s Purdue Frederick and its

subsidiaries helped create the marketing buzz for Librium
and Valium that became the most widespread legal high
pharmaceutical successes. By the 1970s, Valium was the
most highly prescribed pharmaceutical in the world. In
1987 alone, more than 2.8 billion Valium tablets were
made. The Rolling Stones wrote a song about it - Mother’s
Little Helper. Arthur Sackler made a fortune in medical
advertising, and in doing so introduced America to his
version of the drug culture. With the money he made
7
pushing prescription highs he endowed numerous
institutes for advanced scientific research in Israel as well
as the Smithsonian and the Metropolitan Museum of Art in
Manhattan. Sackler was a major financial supporter of the
State of Israel and arranged for an Israeli school to receive
money from New York State as part of a student exchange
program. Arthur died in 1987 leaving behind a fortune in
Oriental art.8 His brothers took over the family business.

In 1991 the Sackler family created Purdue Pharma

as an associated company. In December 1995 Purdue
Pharma began manufacturing and distributing OxyContin
a morphine-like opium-derived time-release painkiller. The
warning label on OxyContin now reads, “OxyContin is an
8
opioid agonist and a Schedule II controlled substance with
an abuse liability similar to morphine. Oxycodone can be
abused in a manner similar to other opioid agonists, legal
or illicit. This should be considered when prescribing or
dispensing OxyContin in situations where the physician or
pharmacist is concerned about an increased risk of
misuse, abuse, or diversion. OxyContin 80 mg and 160
mg Tablets are for use in opioid-tolerant patients only.
These tablet strengths may cause fatal respiratory
depression when administered to patients not previously
exposed to opioids. OxyContin tablets are to be swallowed
whole and are not to be broken, chewed, or crushed.
Taken broken, chewed, or crushed OxyContin tablets
leads to rapid release and absorption of a potentially fatal
dose of Oxycodone.”

In 2002 almost 6-million Americans used OxyContin,

making it the most frequently prescribed narcotic in the
country, according to the DEA. Additionally OxyContin was
being sold illicitly throughout the United States. The heat
was on the Sackler family, who had lied about the dangers
of OxyContin just as their brother Arthur Sackler had lied
about the risks of MER-29. The Sacklers hired Rudy and
Bernie on a consultant basis to make it seem as if Purdue
was serious about combating the smuggling and abuse of
the OxyContin. Kerik was dispatched with other former
police aides to evaluate security practices at Purdue's
9
OxyContin manufacturing plant. About ten months after
Giuliani's firm began its work for Purdue Pharma it also
won a $1.1 million contract from the Department of Justice
to look for ways to improve the effectiveness of the
Organized Crime Drug Enforcement Task Force. In 2002
Asa Hutchinson, who was the director of the Drug
Enforcement Administration, met with Giuliani at a time
when Purdue was under intense scrutiny by the DEA. By
then Giuliani was already helping to raise money for a
DEA (Drug Enforcement Administration) museum. Several
top DEA staffers were recommending that the agency
impose severe sanctions against the drug maker,
including possible restrictions on how much OxyContin it
could make. But Giuliani dissuaded Hutchinson, who
instead focused DEA attention on Edward A. Rosenthal, a
Yippie who was growing marijuana for medical purposes
as an employee of Oakland, California. Federal agents
arrested Rosenthal the same day that Hutchinson gave a
speech in nearby San Francisco. Marijuana enforcement
won out over a morphine-like toxic drug and in September
2003 Purdue won its bid to hold off restrictions on the sale
of OxyContin. In 2004, it paid a $2 million fine to settle the
DEA record-keeping charges without admitting any
wrongdoing.

In 2006 John L. Brownlee a federal prosecutor from

the Western District of Virginia charged that Purdue had,
10
“…promoted OxyContin as less addictive, less subject to
abuse and diversion, and less likely to cause tolerance
and withdrawal than other pain medications, as follows:

a. Trained Purdue sales representatives and told

some health care providers that it was more difficult to
extract the oxycodone from an OxyContin tablet for the
purpose of intravenous abuse, although Purdue's own
study showed that a drug abuser could extract
approximately 68% of the oxycodone from a single 10 mg
OxyContin tablet by crushing the tablet, stirring it in water,
and drawing the solution through cotton into a syringe;

b. Told Purdue sales representatives they could tell

health care providers that OxyContin potentially creates
less chance for addiction than immediate-release opioids;

c. Sponsored training that taught Purdue sales

supervisors that OxyContin had fewer "peak and trough"
blood level effects than immediate release opioids
resulting in less euphoria and less potential for abuse than
short-acting opioids;

d. Told certain health care providers that patients

could stop therapy abruptly without experiencing
withdrawal symptoms and that patients who took
OxyContin would not develop tolerance to the drug; and
11
 e. Told certain health care providers that OxyContin
did not cause a "buzz" or euphoria, caused less euphoria,
had less addiction potential, had less abuse potential, was
less likely to be diverted than immediate-release opioids,
and could be used to "weed out" addicts and drug
seekers.9

In the plea agreement Purdue admitted, “Some

employees violated our company's written policy requiring
that all communications to healthcare professionals about
OxyContin adhere strictly to the FDA-approved prescribing
information for this medicine and its express warnings
about risks. We accept responsibility for those past
misstatements and regret that they were made.”

Brownlee informed Purdue that he was prepared to

indict it and three top executives. Giuliani’s firm was
assigned the task of damage control. In October 2006
Brownlee told Giuliani and Purdue that he expected to ask
for a grand jury indictment by the end of the month. Plea
discussions ensued and Brownlee ultimately agreed that
the three executives would not have to do jail time. The
plea agreements resulted in the following: “Purdue's three
top executives will be convicted criminals and subject to
court supervision; The Purdue Frederick Company, Inc.,
will stand convicted of a felony; Purdue Pharma L.P. will
12
be subject to an extensive corporate integrity agreement
to ensure compliance with all federal laws; Purdue will be
required to set aside $130 million to settle private civil law
suits concerning OxyContin; and the defendants will pay a
total of over $634,000,000 which represents approximately
90% of the profits for sales of OxyContin during the time
period of the offense.”10

When Judge Jones handed out the sentences

recommended by the Justice Department, Michael
Friedman, Howard Udell and Paul Goldenheim each
pleaded guilty to a misdemeanor count of misbranding the
drug. The indictment read, “Defendant Michael Friedman
joined Purdue in 1985 as Vice President and Assistant to
the President and Chairman. He was appointed Group
Vice President in 1988, Executive Vice President and
Chief Operating Officer in 1999, and President and Chief
Executive Officer in 2003. Defendant Howard R. Udell
joined Purdue in 1977 as General Counsel. He was
appointed Group Vice President and General Counsel in
1989, Executive Vice President and General Counsel in
1999, and Executive Vice President and Chief Legal
Officer in 2003. Defendant Paul D. Goldenheim joined
Purdue in 1985 as Medical Director. He was appointed
Vice President and Medical Director in 1986, Vice
President of Scientific and Medical Affairs and Executive
Director of Purdue Frederick Research Center in 1988,
13
Group Vice President of Scientific and Medical Affairs in
1989, Executive Vice President of Medical and Scientific
Affairs in 1999, Executive Vice President of Worldwide
Research & Development in 2000, and Executive Vice
President of Worldwide Research & Development and
Chief Scientific Officer in 2003. He left Purdue in 2004.”11

The Sackler family fully privately owns Purdue

Pharma. Friedman was high up in the corporate hierarchy
but the persons who hold the three most important
positions in the company are: Dr. Mortimer D. Sackler is
the Chairman and 1st Co-CEO, Dr. Raymond R. Sackler,
his brother, is the 2nd Co-CEO, Dr. Richard S. Sackler,
Raymond’s son, is the President. What about the
Sacklers? Raymond Sackler is a member of the
Republican Jewish Coalition. On October 16, 2007
Giuliani addressed and praised this conservative Zionist
group that opposes affirmative action. Did Giuliani get
them immunity from prosecution? How much money did
he get in return? Did he use this money to conduct his
campaign?

WHAT’S THE DIFFERENCE BETWEEN THE SACKLER

FAMILY AND A SACK OF SHIT? THE SACK

THE MASSACHUSETTS AG

14
Dangerous opioid drugs are killing people across
Massachusetts. Prescription medicines, supposed to
protect our health, are instead ruining people’s lives. Every
community in our Commonwealth suffers from the
epidemic of addiction and death.

2. Purdue Pharma created the epidemic and profited from

it through a web of illegal deceit. First, Purdue deceived
Massachusetts doctors and patients to get more and more
people on its dangerous drugs. Second, Purdue misled
them to use higher and more dangerous doses.Third,
Purdue deceived them to stay on its drugs for longer and
more harmful periods of time. All the while, Purdue
peddled falsehoods to keep patients away from safer
alternatives. Even when Purdue knew people in
Massachusetts were addicted and dying, Purdue treated
doctors and their patients as targets to sell more drugs. At
the top of Purdue, a small group of executives led the
deception and pocketed millions of dollars.

3. On behalf of the Commonwealth, the Attorney General

asks the Court to end Purdue’s illegal conduct and make
Purdue and its culpable executives pay for the harm they
inflicted in our state.

15
5. The defendants are two companies and seventeen
individuals who engaged in a deadly, deceptive scheme to
sell opioids in Massachusetts. This Amended Complaint
addresses the bases for jurisdiction and liability as to each
of the nineteen defendants, arising from their decade-long
course of misconduct in Massachusetts that involved
hundreds of deaths, hundreds of thousands of unlawful
acts, and hundreds of millions of dollars.

6. Defendant Purdue Pharma Inc. is a drug company

incorporated in New York with its principal place of
business in Connecticut. It is the general partner of
Defendant Purdue Pharma L.P., a limited partnership
established in Delaware with its principal place of business
in Connecticut. This Complaint refers to Purdue Pharma
Inc. and Purdue Pharma L.P. collectively as “Purdue.”

7. The seventeen individual defendants are current and

former directors and officers of Purdue Pharma Inc. In
Massachusetts, directors, officers, and employees of
corporations are not immune from jurisdiction or liability
when they break the law. Instead, every individual is
accountable for his or her actions.1

8. Defendants Richard Sackler, Beverly Sackler, David

Sackler, Ilene Sackler Lefcourt, Jonathan Sackler, Kathe
Sackler, Mortimer Sackler, and Theresa Sackler controlled
16
Purdue’s misconduct. Each of them took a seat on the
Board of Directors of Purdue Pharma Inc. Together, they
always held the controlling majority of the Board, which
gave them full power over both Purdue Pharma Inc. and
Purdue Pharma L.P. They directed deceptive sales and
marketing practices deep within Purdue, sending
hundreds of orders to executives and line employees.
From the money that Purdue collected selling opioids, they
paid themselves and their family billions of dollars.12

1. New York Times May 12, 1949

2. New York Times May 13, 1950
3. New York Times November 4, 1951
4. New York Times May 8, 1953
5. New York Times April 18, 1957
6. New York Times January 31, 1962
7
https://europepmc.org/articles/pmc1310282/pdf/taos00034-0503.pdf

8. New York Times May 27, 1987

278. Attachment F to Plea Agreement United States v. The Purdue Frederick Co., Inc. Case 1:07-cr-
00029-jpj Document 5 Filed 05/10/2007
10. IN THE USDC For The Western District Of Virginia Abington Division Case No. 1:07CR00029
11
https://archive.org/stream/279028-purdue-guilty-plea/279028-purdue-guilty-plea_djvu.txt
12

https://www.mass.gov/files/documents/2019/01/31/Massachusetts%20AGO%20Amend
ed%20Complaint%202019-01-31.pdf

17